Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,048 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger PB, Ledermann JA, Khaw P, Colombo A, Fyles A, Baron MH, Jürgenliemk-Schulz IM, Kitchener HC, Nijman HW, Wilson G, Brooks S, Carinelli S, Provencher D, Hanzen C, Lutgens LCHW, Smit VTHBM, Singh N, Do V, D'Amico R, Nout RA, Feeney A, Verhoeven-Adema KW, Putter H, Creutzberg CL; PORTEC study group. de Boer SM, et al. Among authors: colombo a. Lancet Oncol. 2018 Mar;19(3):295-309. doi: 10.1016/S1470-2045(18)30079-2. Epub 2018 Feb 12. Lancet Oncol. 2018. PMID: 29449189 Free PMC article. Clinical Trial.
Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial.
de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger PB, Ledermann JA, Khaw P, Colombo A, Fyles A, Baron MH, Kitchener HC, Nijman HW, Kruitwagen RF, Nout RA, Verhoeven-Adema KW, Smit VT, Putter H, Creutzberg CL; PORTEC study group. de Boer SM, et al. Among authors: colombo a. Lancet Oncol. 2016 Aug;17(8):1114-1126. doi: 10.1016/S1470-2045(16)30120-6. Epub 2016 Jul 7. Lancet Oncol. 2016. PMID: 27397040 Free article. Clinical Trial.
Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy--a multicenter randomized trial.
Olmi P, Crispino S, Fallai C, Torri V, Rossi F, Bolner A, Amichetti M, Signor M, Taino R, Squadrelli M, Colombo A, Ardizzoia A, Ponticelli P, Franchin G, Minatel E, Gobitti C, Atzeni G, Gava A, Flann M, Marsoni S. Olmi P, et al. Among authors: colombo a. Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1):78-92. doi: 10.1016/s0360-3016(02)03792-6. Int J Radiat Oncol Biol Phys. 2003. PMID: 12504039 Clinical Trial.
Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study.
Benedetti-Panici P, Greggi S, Colombo A, Amoroso M, Smaniotto D, Giannarelli D, Amunni G, Raspagliesi F, Zola P, Mangioni C, Landoni F. Benedetti-Panici P, et al. Among authors: colombo a. J Clin Oncol. 2002 Jan 1;20(1):179-88. doi: 10.1200/JCO.2002.20.1.179. J Clin Oncol. 2002. PMID: 11773168 Free article. Clinical Trial.
Practice patterns of radiotherapy in cervical cancer among member groups of the Gynecologic Cancer Intergroup (GCIG).
Gaffney DK, Du Bois A, Narayan K, Reed N, Toita T, Pignata S, Blake P, Portelance L, Sadoyze A, Pötter R, Colombo A, Randall M, Mirza MR, Trimble EL. Gaffney DK, et al. Among authors: colombo a. Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):485-90. doi: 10.1016/j.ijrobp.2006.12.013. Epub 2007 Mar 2. Int J Radiat Oncol Biol Phys. 2007. PMID: 17336465
Implementing Standard Diagnosis and Treatment for Locally Advanced Breast Cancer Through Global Research in Latin America: Results From a Multicountry Pragmatic Trial.
Retamales J, Daneri-Navarro A, Artagaveytia N, Alves da Quinta D, Abdelhay E, Podhajcer OL, Velázquez C, Giunta D, Crocamo S, Garibay-Escobar A, Del Toro-Arreola A, Rodriguez R, Aghazarian M, Alcoba E, Alonso I, Binato R, Bravo AI, Canton-Romero J, Carraro DM, Castro M, Castro-Cervantes J, Cataldi S, Camejo N, Cortes-Sanabria L, Flores-Marquez M, Laviña G, Musetti E, Caserta B, Cerda M, Colombo A, Delgadillo-Cristerna R, Dreyer Breitenbach M, Fernandez E, Fernandez J, Franco-Topete R, Gabay C, Gaete F, Gamboa J, García-Gaeta R, Gomez Del Toro M, Gonzalez-Ramirez LP, Guerrero M, Herrera-Miramontes M, Lopez-Vasquez A, Maldonado S, Morán-Mendoza A, Morgan-Villela G, Nagai MA, Navarro-Ruiz N, Oceguera-Villanueva A, Ortiz MA, Quintero J, Quintero-Ramos A, Ramirez-Rosales G, Ramos-Ramirez M, Chiquitelli Marques MM, Rivera Claisse E, Rodriguez-Gonzalez D, Romero-Gomez A, Rosales C, Salas-Gonzalez E, Sanchotena V, Segovia L, Silva-García AA, Valenzuela-Antelo O, Venegas-Godinez L, Zagame L, Gomez J; Latin American Cancer Research Network (LACRN); Llera AS, Müller B. Retamales J, et al. Among authors: colombo a. JCO Glob Oncol. 2024 May;10:e2300216. doi: 10.1200/GO.23.00216. JCO Glob Oncol. 2024. PMID: 38723219 Clinical Trial.
3,048 results